title: [Botulinum toxin in the elderly to the care of limbs spastic hypertonia and toes or fingers dystonias].
abstract: OBJECTIVE
  To show the botulinum toxin interest and limits in the elderly presenting a limbs spastic hypertonia and/or a dystonia, through a clinical study and a literature review.
  
  
  METHODS
  We report a 6 years and 8 months retrospective single center study, concerning 49 patients, all of them was more than 70 years old and had received one or several botulinum toxin injections for a limbs spastic hypertonia and/or a dystonia.
  
  
  RESULTS
  The population average was 76,9 years old (70 to 92 years old). It was possible to realize several sessions for the same patient if respecting a three months interval between two sessions. No major side effects was noticed. More than half of the patients felt a significant improvement of their life quality, their functional status and/or on pain. A multidisciplinary care was systematically associated with the botulinum toxin.
  
  
  CONCLUSIONS
  The botulinum toxin is an additional asset for the spasticity care of the geriatric patient in rehabilitation, if indications and contraindications are advisedly targeted. The age cannot be considered as a limitating factor.
authors.affiliation: Unité de médecine physique et de réadaptation, Hôpital La Charité, CHU de Saint-Étienne. cedric.chol@chu-st-etienne.fr
authors.forename: Cédric
authors.initials: C
authors.lastname: Chol
authors.forename: Marie-Ange
authors.initials: MA
authors.lastname: Blanchon
authors.forename: Bénédicte
authors.initials: B
authors.lastname: Le Quang
authors.forename: Thomas
authors.initials: T
authors.lastname: Celarier
authors.forename: Régis
authors.initials: R
authors.lastname: Gonthier
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D003299:Cooperative Behavior; D004421:Dystonia / Q000534:rehabilitation*; D005121:Extremities; D005260:Female; D005385:Fingers; D005602:France; D006801:Humans; D007273:Injections, Intramuscular; D033183:Interdisciplinary Communication; D008297:Male; D051346:Mobility Limitation; D009122:Muscle Hypertonia / Q000534:rehabilitation*; D009128:Muscle Spasticity / Q000534:rehabilitation*; D009460:Neurologic Examination; D026741:Physical Therapy Modalities; D012189:Retrospective Studies; D014034:Toes
chemical_list: D019274:Botulinum Toxins, Type A